Back to Screener

Healthcare

Crescent Biopharma, Inc.(CBIO)

Live Price

Offline

$16.84

-3.00% today

1Y Change

-2.78%

Window

Jun 25, 2025 โ†’ Jun 23, 2026

Market Cap
$500.00M
Revenue Growth
0.0%
EPS Growth
-955.7%
Dividend Yield
0.0%

Coverage: 249 bars ยท Jun 25, 2025 โ†’ Jun 23, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Crescent Biopharma, Inc. (CBIO) is a Healthcare stock with a market cap of $500.00M. The stock last traded around $16.84 and down 2.8% across the available one-year price window (Jun 25, 2025 โ†’ Jun 23, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of -955.7%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS -955.7%, free cash flow -132.9% with operating margin -1372.9% and ROIC -88.0%. Valuation already assumes a fairly strong business story at price/sales 42.0. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines CBIO price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

CBIO vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

CBIO

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

CBIO Max Drawdown

-50.33%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for CBIO and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

๐Ÿ“… Last reportedMay 13, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
โ€”
May 13, 26
โ€”
Est -0.85
โ€”
โ€”
Est 357.1B
โ€”
May 13
โ€”
Feb 26, 26
โœ—
-4.01
Est -2.22
-80.6%
10844.0B
Est 10000.0B
+8.4%
Feb 26
โ€”
Nov 6, 25
โœ—
-1.27
Est -1.01
-25.7%
โ€”
Est โ€”
โ€”
Nov 6
โ€”
Jul 31, 25
โœ—
-4.93
Est -2.69
-83.3%
โ€”
Est โ€”
โ€”
Jul 31
โ€”
May 14, 25
โœ“
-0.04
Est -0.05
+20.0%
โ€”
Est โ€”
โ€”
May 14
โ€”
Feb 13, 25
โœ“
-0.11
Est -0.16
+31.3%
54.1B
Est โ€”
โ€”
Feb 13
โ€”
Nov 13, 24
โœ—
-0.15
Est -0.11
-36.4%
โ€”
Est โ€”
โ€”
Nov 13
โ€”
Aug 8, 24
โœ“
-0.16
Est -0.17
+5.9%
โ€”
Est โ€”
โ€”
Aug 8
โ€”
May 9, 24
โœ—
-0.17
Est -0.16
-6.3%
โ€”
Est โ€”
โ€”
May 9
โ€”
Mar 27, 24
โœ“
-0.14
Est -0.15
+6.7%
10.0B
Est โ€”
โ€”
Mar 27
โ€”
Nov 3, 23
โ€”
-0.14
Est -0.14
0.0%
โ€”
Est โ€”
โ€”
Nov 3
โ€”
Aug 2, 23
โœ“
-0.13
Est -0.18
+27.8%
โ€”
Est 50.0B
โ€”
Aug 2
โ€”
May 3, 23
โ€”
-0.17
Est -0.17
0.0%
โ€”
Est โ€”
โ€”
May 3
โ€”
Mar 29, 23
โœ—
-0.19
Est -0.17
-11.8%
75M
Est โ€”
โ€”
Mar 29
โ€”
Nov 9, 22
โœ“
-0.16
Est -0.26
+38.5%
โ€”
Est โ€”
โ€”
Nov 9
โ€”
Aug 3, 22
โœ“
-0.25
Est -0.29
+13.8%
75.0B
Est โ€”
โ€”
Aug 3
โ€”
Apr 28, 22
โœ“
-0.28
Est -0.31
+9.7%
โ€”
Est โ€”
โ€”
Apr 28
โ€”
Mar 3, 22
โœ—
-0.33
Est -0.31
-6.5%
18.0B
Est โ€”
โ€”
Mar 3
โ€”
Nov 2, 21
โœ—
-0.34
Est -0.32
-6.3%
86.6B
Est 81.2B
+6.7%
Nov 2
โ€”
Aug 5, 21
โœ“
-0.28
Est -0.31
+9.7%
142M
Est 155M
-8.4%
Aug 5
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the calendar screener